 Hepatic tomography iron status haemodialysis patients haemosiderosis recombinant human erythropoietin randomized partial-crossover study uraemic patients dialysis-associated anaemia transfusional iron overload effects desferrioxamine chelation therapy recombinant human erythropoietin treatment hepatic iron storage computed tomography serum ferritin concentration transferrin saturation haemodialysis patients moderate iron overload values serum ferritin concentration transferrin saturation hepatic tomography density micrograms/l Hounsfield units groups months first months group desferrioxamine chelation therapy mg/kg times week group underwent recombinant human erythropoietin treatment units/kg times week Thereafter second months observation patients group recombinant human erythropoietin poor response desferrioxamine-treated group initial months patients group maintenance dose recombinant human erythropoietin times week end trial Patients group placebo study comparison placebo recombinant human erythropoietin treatment desferrioxamine chelation therapy serum ferritin concentration transferrin saturation hepatic tomography density rise haemoglobin cell volume Hepatic tomography density serum ferritin concentration transferrin saturation patients treatment recombinant human erythropoietin